IL6 and COVID-19: Studies have shown that systemic administration of ozone in COVID-19 patients shortened hospitalization time, reduced proinflammatory cytokine levels (IL-2, IL-6, IL-8, TNF-α), and simultaneously increased concentrations of the anti-inflammatory cytokine IL-10 [41].